[go: up one dir, main page]

UY35745A - Derivados sustituidos de fenilalanina - Google Patents

Derivados sustituidos de fenilalanina

Info

Publication number
UY35745A
UY35745A UY0001035745A UY35745A UY35745A UY 35745 A UY35745 A UY 35745A UY 0001035745 A UY0001035745 A UY 0001035745A UY 35745 A UY35745 A UY 35745A UY 35745 A UY35745 A UY 35745A
Authority
UY
Uruguay
Prior art keywords
phenylalanine
substituted derivatives
preparation
diseases
perioperative
Prior art date
Application number
UY0001035745A
Other languages
English (en)
Inventor
Dr Anja Buchmüller
Dr Christoph Gerdes
Dr Stefan Heitmeier
Prof Dr Alexander Hillisch
Dr Martina Victoria Schmidt
Julia Strassburger
Dr Adrian Tersteegen
Dr Uirike Röhn
Dr Manuel Ellermann
Dr Astrid Wendt
Dr Robert Alan Webster
Dr Kristin Beyer
Dr Martina Schäfer
Dr Michael Sperzel
Dr Steffen Sandmann
Dr Jens Ackerstaff
Dr Carsten Terjung
Dr Susanne Röhrig
Original Assignee
Bayer Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Pharma AG filed Critical Bayer Pharma AG
Publication of UY35745A publication Critical patent/UY35745A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08—Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La invención se refiere a derivados sustituidos de fenilalanina y procedimiento para su preparación, así como a su uso para la preparación de medicamentos para el tratamiento y/o la prevención de enfermedades, en especial de enfermedades cardiovascu lares y/o de fuerte pérdida de sangre perioperatoria.
UY0001035745A 2013-09-26 2014-09-24 Derivados sustituidos de fenilalanina UY35745A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP13186056 2013-09-26

Publications (1)

Publication Number Publication Date
UY35745A true UY35745A (es) 2015-04-30

Family

ID=49231353

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001035745A UY35745A (es) 2013-09-26 2014-09-24 Derivados sustituidos de fenilalanina

Country Status (6)

Country Link
US (1) US20160222056A1 (es)
EP (1) EP3049404A1 (es)
AR (1) AR097754A1 (es)
TW (1) TW201605828A (es)
UY (1) UY35745A (es)
WO (1) WO2015044165A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6479763B2 (ja) 2013-03-25 2019-03-06 ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ 第ｘｉａ因子阻害剤としての置換アゾール含有のテトラヒドロイソキノリン
NO2760821T3 (es) 2014-01-31 2018-03-10
ES2687498T3 (es) 2014-01-31 2018-10-25 Bristol-Myers Squibb Company Macrociclos con grupos P2¿ heterocíclicos como inhibidores del factor XIa
ES2714283T3 (es) 2014-09-04 2019-05-28 Bristol Myers Squibb Co Macrociclos de diamida que son inhibidores de FXIa
US9453018B2 (en) 2014-10-01 2016-09-27 Bristol-Myers Squibb Company Pyrimidinones as factor XIa inhibitors
WO2017074833A1 (en) 2015-10-29 2017-05-04 Merck Sharp & Dohme Corp. Macrocyclic spirocarbamate derivatives as factor xia inhibitors, pharmaceutically acceptable compositions and their use
WO2018039094A1 (en) 2016-08-22 2018-03-01 Merck Sharp & Dohme Corp. Pyridine-1-oxide derivatives and their use as factor xia inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101137412B (zh) * 2005-01-13 2012-11-07 布里斯托尔-迈尔斯·斯奎布公司 用作凝血因子XIa抑制剂的取代的二芳基化合物
WO2007070816A2 (en) * 2005-12-14 2007-06-21 Bristol-Myers Squibb Company Thiophene derivatives as factor xia inhibitors
WO2011154677A1 (en) * 2010-06-09 2011-12-15 Astrazeneca Ab Substituted n-[1-cyano-2-(phenyl)ethyl] 1-aminocycloalk-1-ylcarboxamide compounds - 760

Also Published As

Publication number Publication date
US20160222056A1 (en) 2016-08-04
AR097754A1 (es) 2016-04-13
TW201605828A (zh) 2016-02-16
EP3049404A1 (de) 2016-08-03
WO2015044165A1 (de) 2015-04-02

Similar Documents

Publication Publication Date Title
MX2016008131A (es) Compuestos heterociclos biciclicos y sus usos en terapia.
CO2017011851A2 (es) Compuestos novedosos
UY35747A (es) Derivados sustituidos de fenilalanina
SV2018005610A (es) Derivados de oxopiridina sustituidos
NI201600144A (es) Derivados de quinoxalina utiles como moduladores del fgfr cinasa
DOP2015000246A (es) Derivados de oxopiridina sustituida y usos de los mismos en el tratamiento de trastornos cardiovasculares
UY34918A (es) Nuevos ácidos 5-aminotetrahidroquinolin-2-carboxílicos y su uso
IL257379A (en) Diacerein or its analogs for inhibiting expression of asc, nlrp3, and/or formation of nlrp3 inflammasome complex
CL2016001895A1 (es) Compuestos
EA201692301A1 (ru) Производные бороновой кислоты и их терапевтическое применение
UY36544A (es) Derivados de 4h-pirrol[3,2-c]piridin-4-ona
JOP20140114B1 (ar) مركبات حلقية غير متجانسة واستخداماتها
UY34657A (es) ?derivados macrocíclicos para el tratamiento de enfermedades?.
DOP2014000255A (es) Uracilos sustituidos bicíclicamente y uso de los mismos
MX2021014242A (es) Uso de linagliptina en terapia antidiabetica cardio- y renoprotectora.
CL2014001865A1 (es) Compuestos derivados de fosfatos; procedimiento de preparacion; composiciones farmaceuticas que los contienen y uso en el tratamiento del cancer.
MX387235B (es) Derivados de pirazolopiridina y su uso en terapia
UY35745A (es) Derivados sustituidos de fenilalanina
HUE051296T2 (hu) Benzoxazinon-származékok bõrbetegségek kezelésére
CR20170008A (es) Compuestos de [1,2,4] triazol e imidazol sustituidos
UY35746A (es) Derivados de fenilalanina sustituidos
MX2016012784A (es) Composiciones farmaceuticas solidas que comprenden derivados de biopterina y usos de tales composiciones.
PE20150167A1 (es) (r)-nifuratel, su uso para el tratamiento de las infecciones y sintesis de (r) y (s)-nifuratel
MX2017013137A (es) Derivados de cromeno como inhibidores de las fosfoinositido-3-cina sas.
MX2017012596A (es) Una composicion farmaceutica y el uso de la misma.

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20211207